Search

Your search keyword '"Menarche drug effects"' showing total 108 results

Search Constraints

Start Over You searched for: Descriptor "Menarche drug effects" Remove constraint Descriptor: "Menarche drug effects"
108 results on '"Menarche drug effects"'

Search Results

1. Effects of growth hormone therapy on the onset and progression of pubertal development in girls with idiopathic short stature.

2. Timing of onset of menses after GnRH agonist treatment for central precocious puberty.

3. Anthropometric, metabolic, and reproductive outcomes of patients with central precocious puberty treated with leuprorelin acetate 3-month depot (11.25 mg).

4. Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis.

5. Menarche in primary ovarian insufficiency after a month of hormone replacement therapy: a case report.

6. The impact of gender, puberty, and pregnancy in patients with POLG disease.

7. Migraine: navigating the hormonal minefield.

8. Early lead exposure and pubertal development in a Mexico City population.

9. Prenatal lead exposure in relation to age at menarche: results from a longitudinal study in Mexico City.

10. Childhood and adolescent phenol and phthalate exposure and the age of menarche in Latina girls.

11. Impact of zinc on sexual maturation of female sickle cell anemia (SCA) children in Enugu, Southeast Nigeria.

12. Age at Pubertal Onset in Girls and Tobacco Smoke Exposure During Pre- and Postnatal Susceptibility Windows.

13. In utero exposure to atrazine analytes and early menarche in the Avon Longitudinal Study of Parents and Children Cohort.

14. Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature.

15. The hormonal sensitivity hypothesis: A review and new findings.

16. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.

17. Associations of urinary phthalate and phenol biomarkers with menarche in a multiethnic cohort of young girls.

18. Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.

19. Reply to RE Kleinman.

21. Consumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche.

22. Childhood Passive Smoking Exposure and Age at Menarche in Chinese Women Who Had Never Smoked: The Guangzhou Biobank Cohort Study.

23. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.

24. Sugar-sweetened beverage consumption and age at menarche in a prospective study of US girls.

25. Impact of BMI on gonadorelin-stimulated LH peak in premenarcheal girls with idiopathic central precocious puberty.

26. Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report.

27. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

29. Menarche, menopause, years of menstruation, and the incidence of osteoporosis: the influence of prenatal exposure to diethylstilbestrol.

30. Dental sealants and flowable composite restorations and psychosocial, neuropsychological, and physical development in children.

31. Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction.

32. Does vitamin D affect timing of menarche?

35. Maternal smoking during pregnancy and reproductive health of daughters: a follow-up study spanning two decades.

36. Dental composites and amalgam and physical development in children.

37. Short-term secular variation in menarche and blood lead concentration in school girls in the Copper Basin of southwestern Poland: 1995 and 2007.

38. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy.

39. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.

40. Early-life soy exposure and age at menarche.

41. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

42. Leptin substitution results in the induction of menstrual cycles in an adolescent with leptin deficiency and hypogonadotropic hypogonadism.

43. Age at menarche in childhood cancer survivors: results of a nationwide survey in Germany.

44. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.

45. Serum PBDEs and age at menarche in adolescent girls: analysis of the National Health and Nutrition Examination Survey 2003-2004.

46. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.

47. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand.

48. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.

49. Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort.

50. Smoking and alcohol use during pregnancy and age of menarche in daughters.

Catalog

Books, media, physical & digital resources